doi: 10.3389/fphar.2025.1737199 Received 01 November 2025 Revised 21 December 2025 Accepted 29 December 2025 Published 15 January 2026 Volume 16 - 2025 Edited by Dawei Chen, University of Kiel, Germany Reviewed by Eveljn Scarian, University of Pavia, Italy Hong Cheng, Yangzhou University, China Updates Copyright 2026 Knudsen, Tadje, Coggins and Venketaraman
The result is a clear, colorless liquid without odor (or with a very faint characteristic odor of benzyl alcohol), ready to serve as a reliable solvent for sensitive peptide molecules
It struck me that a third of treatment-eligible patients may not have been represented in these pivotal clinical trials, yet little attention is given to how the exclusion criteria of trials may impact a trials generalizability, Lily G
Torres-Perez E, Ledesma M, Garcia-Sobreviela MP, Leon-Latre M, Arbones-Mainar JM
The risk is not worth assuming safety based on molecular structure alone
10.1016/j.cell.2013.12.010 59 YangY.TangB